_D0A9018_ skiss

Clinical evidence for predictable outcomes

Cavix was founded on our conviction that pets deserve nothing less than the best available care. Essential to achieving this is to assure that all Cavix products are grounded in established clinical evidence, starting with pre-clinical, safety and biocompatibility testing, and all the way through to clinical evaluation. Thorough documentation is therefore the foundation for any product we bring to market.

The first Cavix product, a synthetic bone graft based on our proprietary bone regenerative ceramic material, is currently in clinical documentation phase to ensure that pets, their owners and surgeons can rest assured that their treatment outcomes are predictable, with the highest possible level of care.

Current status of Cavix synthetic bone graft

Pre-clinical proof of concept

Porcine, spinal clinical model at Swedish University of Agricultural Sciences

  • CT follow-up at 3 month intervals

  • PET/CT and histology at termination

Clinical evaluation with companion animals at Vetsuisse Faculty University of Berne

  • Inclusion ongoing

  • CT follow-up at 3 month intervals

Clinical reference centers

  • Inclusion ongoing to establish a number of reference centers in Europe and the US to document broader user experiences and outcomes.

If you are interested in learning more about our technology, enrolling as a reference center, or exploring other partnership opportunities, see our Partnering Opportunities

This website uses cookiesfor statistics and user experience.

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.